Associate Professor Ben Lacey
MBChB MSc DPhil FFPH
Ben Lacey is an epidemiologist and public health physician. He leads the UK Biobank Epidemiology Group, based at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford.
His work supports the conduct of UK Biobank, focusing particularly on the enhancement of the study through linkage with routine health-related datasets. His main research interests are in the socio-economic and lifestyle determinants of health.
He qualified in medicine from the University of Edinburgh, and received an MSc in Global Health Science and a DPhil in Epidemiology from the University of Oxford.
He is an Honorary Consultant Physician in Public Health at Oxford University Hospitals NHS Trust, a Fellow of the Faculty of Public Health of the Royal Colleges of Physicians, and a Member of Common Room at Green Templeton College, Oxford.
Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses.
Dimou N. et al, (2022), Cancer Epidemiol Biomarkers Prev, OF1 - OF10
Associations of adiposity, kidney stone disease, and serum calcium concentrations; observational and genetic epidemiological studies
Lovegrove CE. et al, (2022)
Unequal impact of the Covid-19 pandemic on excess deaths, life expectancy, and premature mortality across Spanish regions in 2020 and 2021
Islam N. et al, (2021)
Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis.
Li C. et al, (2021), BMJ Open, 11
Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries.
Islam N. et al, (2021), BMJ, 375
Association of Smoking Initiation and Cessation Across the Life Course and Cancer Mortality: Prospective Study of 410 000 US Adults.
Thomson B. et al, (2021), JAMA Oncol